SG121739A1 - Stabilized protein crystals, formulations containing them and methods of making them - Google Patents

Stabilized protein crystals, formulations containing them and methods of making them

Info

Publication number
SG121739A1
SG121739A1 SG200206394A SG200206394A SG121739A1 SG 121739 A1 SG121739 A1 SG 121739A1 SG 200206394 A SG200206394 A SG 200206394A SG 200206394 A SG200206394 A SG 200206394A SG 121739 A1 SG121739 A1 SG 121739A1
Authority
SG
Singapore
Prior art keywords
making
methods
formulations containing
protein crystals
stabilized protein
Prior art date
Application number
SG200206394A
Other languages
English (en)
Inventor
Alexey L Margolin
Nazer K Khalaf
Clair Nancy L St
Scott L Rakestraw
Bhami C Shenoy
Original Assignee
Altus Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altus Pharmaceuticals Inc filed Critical Altus Pharmaceuticals Inc
Publication of SG121739A1 publication Critical patent/SG121739A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C12N9/80—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
    • C12N9/84—Penicillin amidase (3.5.1.11)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Enzymes And Modification Thereof (AREA)
SG200206394A 1998-04-27 1999-04-27 Stabilized protein crystals, formulations containing them and methods of making them SG121739A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8314898P 1998-04-27 1998-04-27
US22447598A 1998-12-31 1998-12-31

Publications (1)

Publication Number Publication Date
SG121739A1 true SG121739A1 (en) 2006-05-26

Family

ID=26768988

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200206394A SG121739A1 (en) 1998-04-27 1999-04-27 Stabilized protein crystals, formulations containing them and methods of making them

Country Status (5)

Country Link
EP (1) EP1073421A1 (ja)
JP (1) JP4965022B2 (ja)
AU (1) AU757991B2 (ja)
CA (1) CA2330476A1 (ja)
SG (1) SG121739A1 (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG176314A1 (en) * 2002-12-31 2011-12-29 Altus Pharmaceuticals Inc Human growth hormone crystals and methods for preparing them
CA2512001A1 (en) * 2002-12-31 2004-07-22 Altus Pharmaceuticals Inc. Complexes of protein crystals and ionic polymers
CN1826170B (zh) * 2003-07-18 2010-12-08 巴克斯特国际公司 通过受控相分离制备的小球形颗粒的制造方法、其用途和成分
EP1928551B1 (en) * 2005-06-10 2012-05-30 Althea Technologies, Inc. Methods to reduce oxalate concentration by administration of oxalate oxidase crystals
US7842312B2 (en) * 2005-12-29 2010-11-30 Cordis Corporation Polymeric compositions comprising therapeutic agents in crystalline phases, and methods of forming the same
US8323685B2 (en) * 2008-08-20 2012-12-04 Baxter International Inc. Methods of processing compositions containing microparticles
CN116328782A (zh) * 2021-12-24 2023-06-27 中国石油天然气股份有限公司 含钛渣油加氢脱金属催化剂及其制备方法

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0134318A2 (en) * 1983-06-10 1985-03-20 Connaught Laboratories Limited Controlled release of injectable and implantable insulin compositions
WO1996018417A1 (en) * 1994-12-14 1996-06-20 Schering Corporation Crystalline protein controlled release compositions
WO1996041873A1 (en) * 1995-06-09 1996-12-27 The Regents Of The University Of California Dry powder formulations of polynucleotide complexes
WO1998042749A1 (en) * 1997-03-20 1998-10-01 Novo Nordisk A/S Zinc free insulin crystals for use in pulmonary compositions
WO1998046732A1 (en) * 1997-04-11 1998-10-22 Altus Biologics Inc. Controlled dissolution cross-linked protein crystals

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5585466A (en) * 1994-12-06 1996-12-17 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Crystals of serum albumin for use in genetic engineering and rational drug design
ATE233784T1 (de) * 1996-03-15 2003-03-15 Novozymes As Verfahren zur proteinaufreinigung aus einer proteinhaltigen lösung
US5932212A (en) * 1996-05-24 1999-08-03 Altus Biologics, Inc. Crosslinked protein crystal formulations and their use as catalysts in organic solvents

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0134318A2 (en) * 1983-06-10 1985-03-20 Connaught Laboratories Limited Controlled release of injectable and implantable insulin compositions
WO1996018417A1 (en) * 1994-12-14 1996-06-20 Schering Corporation Crystalline protein controlled release compositions
WO1996041873A1 (en) * 1995-06-09 1996-12-27 The Regents Of The University Of California Dry powder formulations of polynucleotide complexes
WO1998042749A1 (en) * 1997-03-20 1998-10-01 Novo Nordisk A/S Zinc free insulin crystals for use in pulmonary compositions
WO1998046732A1 (en) * 1997-04-11 1998-10-22 Altus Biologics Inc. Controlled dissolution cross-linked protein crystals

Also Published As

Publication number Publication date
AU757991B2 (en) 2003-03-13
JP2002512949A (ja) 2002-05-08
EP1073421A1 (en) 2001-02-07
JP4965022B2 (ja) 2012-07-04
CA2330476A1 (en) 1999-11-04
AU3764699A (en) 1999-11-16

Similar Documents

Publication Publication Date Title
PL339463A1 (en) April - novel protein of growth promoting action
EP1113799A4 (en) PROTEIN-BASED PREPARATION
PL330841A1 (en) Benzosulphonic derivatives, method of obtaining them and therapeutic agents containing such derivatives
ZA986822B (en) Reduction of hair growth
IL141403A0 (en) Deleted adenoviruses and methods of making and administering the same
HK1026151A1 (en) Stabilized protein compositions
AU3789399A (en) Indolicidin analogs and methods of using same
HK1041827B (zh) 用於治療雌激素依賴性疾病的化合物以及製備和使用上述化合物的方法
AU1201099A (en) Stabilized whitening compositions and method of preparing same
HK1044156A1 (en) Camptothecin analogs and methods of preparation thereof.
AU4992299A (en) Uncoupling protein 4 (ucp-4) and methods of use
SG121739A1 (en) Stabilized protein crystals, formulations containing them and methods of making them
AU3964499A (en) Agouti-related protein analogs and methods of use
EP1140975A4 (en) SUBTILINE STABLE AND METHODS OF PREPARING SAME
EP1140121A4 (en) CRYOGRANULATION OF ACTIVATED PROTEIN C
HUP9902855A3 (en) Preparation of sterol- and stanol-esters
AU5649299A (en) Protein solution preparation and method for stabilizing the same
PL334144A1 (en) Novel derivatives of pyrolydine, composition containing and method of obtaining them
AU2221400A (en) Compositions containing and methods of using n-acyl-1h-aminoindenes
AU2766597A (en) Biologically active protein (collagen fragment hf-coll-18/514cf) for inhibiting the growth of tumours and capillary profilerations
GB9811962D0 (en) Vertebrate homologue of UNC-53 protein of C.elegans
HUP0102577A3 (en) Seeding crystals for the preparation of peptides or proteins, process for their preparation and their use
PL336806A1 (en) Novel nitromethyl ketones, method of obtaining them and preparations containing such compounds
AU5470099A (en) Products containing unpleasant tasting bio-affecting agents and methods of making them
AU6427899A (en) Preparation of mono- and di-arylphosphines